Are You Looking for a Top Momentum Pick? Why Coca-Cola European (CCEP) is a Great Choice — Positive
CCEP Zacks Investment Research — March 28, 2025Does Coca-Cola European (CCEP) have what it takes to be a top stock pick for momentum investors? Let's find out.

All You Need to Know About Expand Energy (EXE) Rating Upgrade to Strong Buy — Positive
EXE Zacks Investment Research — March 28, 2025Expand Energy (EXE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

RBC Bearings (RBC) Upgraded to Strong Buy: Here's Why — Positive
RBC Zacks Investment Research — March 28, 2025RBC Bearings (RBC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GCT Semiconductor Holding, Inc. (GCTS) Upgraded to Buy: What Does It Mean for the Stock? — Positive
GCTS Zacks Investment Research — March 28, 2025GCT Semiconductor Holding, Inc. (GCTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

What Makes Hanmi Financial (HAFC) a New Strong Buy Stock — Positive
HAFC Zacks Investment Research — March 28, 2025Hanmi Financial (HAFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's What You Should Know — Positive
ACRV Zacks Investment Research — March 28, 2025Acrivon Therapeutics, Inc. (ACRV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Southern Missouri Bancorp (SMBC) Upgraded to Strong Buy: Here's Why — Positive
SMBC Zacks Investment Research — March 28, 2025Southern Missouri Bancorp (SMBC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Atossa Genetics (ATOS) Rating Upgrade to Buy — Positive
ATOS Zacks Investment Research — March 28, 2025Atossa Genetics (ATOS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Alexander's (ALX) Upgraded to Strong Buy: Here's Why — Positive
ALX Zacks Investment Research — March 28, 2025Alexander's (ALX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BitFuFu Inc. (FUFU) Upgraded to Strong Buy: Here's What You Should Know — Positive
FUFU Zacks Investment Research — March 28, 2025BitFuFu Inc. (FUFU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

All You Need to Know About Qifu Technology, Inc. (QFIN) Rating Upgrade to Strong Buy — Positive
QFIN Zacks Investment Research — March 28, 2025Qifu Technology, Inc. (QFIN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

TFS Financial Corp: A Long-Forgotten Second-Step Thrift Conversion Can Still Provide Value — Positive
TFSL Seeking Alpha — March 28, 2025TFS Financial Corporation offers a steady 9%+ dividend yield, making it an attractive option for income-focused investors despite its complex share structure. The company's consistent performance through various economic cycles and interest rate environments highlights its resilience and strong management. TFSL's valuation is convoluted due to its split ownership, but its public float trades at a very cheap price-to-book ratio of 0.34x.

ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript — Neutral
IPA Seeking Alpha — March 28, 2025ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C.

S&P Global Mobility: March 2025 US auto sales potentially ride one last wave — Neutral
SPGI PRNewsWire — March 28, 2025S&P Global Mobility projects that US auto sales in March will crest over 1.45 million units, as consumers and automakers try to get ahead of tariffs SOUTHFIELD, Mich. , March 28, 2025 /PRNewswire/ -- With volume for the month projected at 1.45 million units, March 2025 U.S. auto sales are estimated to translate to an estimated sales pace of 16.3 million units (seasonally adjusted annual rate: SAAR), according to S&P Global Mobility.

Vista Gold to Present at the Mining Forum Europe 2025 Conference — Neutral
VGZ Business Wire — March 28, 2025DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) announced today that Frederick H. Earnest, President and CEO of Vista, will be speaking at the Mining Forum Europe 2025 conference in Zurich, Switzerland. Mr. Earnest's presentation is scheduled for Wednesday, April 2, at 1:10 pm Zurich time (5:10 a.m. MDT or 7:10 a.m. EDT). The session will be live-streamed and available for on-demand viewing starting Friday, April 4. It can be accessed on the Company's website at www.vista.

Coca-Cola (KO) Price Prediction and Forecast 2025-2030 (March 2025) — Neutral
KO 24/7 Wall Street — March 28, 2025Shares of Coca-Cola ( NYSE: KO ) remained mostly flat over the past month, experiencing a -0.39% loss compared to the S&P 500's loss of -5.76% over the same period.

FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer — Neutral
NVS GlobeNewsWire — March 28, 2025Ad hoc announcement pursuant to Art. 53 LR New indication approximately triples eligible patient population, allowing Pluvicto® to be used after one androgen receptor pathway inhibitor (ARPI) and now before chemotherapy Pluvicto significantly reduced risk of progression or death by 59% and more than doubled median radiographic progression-free survival ( rPFS) vs.

Quantum Computing D-Wave News - FAANG Data Science 2025 Interview Prep Course Questions MCQ Answers And Mock Interviews Updated — Neutral
QBTS GlobeNewsWire — March 28, 2025Santa Clara, March 28, 2025 (GLOBE NEWSWIRE) -- Santa Clara, California - As quantum computing reaches new milestones with D-Wave's recent claim of "quantum supremacy" in magnetic materials simulation, Interview Kickstart announces the launch of its comprehensive Data Science Interview Masterclass, designed to prepare technical professionals for the rapidly evolving computational landscape. To learn more about the course, visit: https://interviewkickstart.com/courses/data-science-course Last week, D-Wave published research in the scientific journal Science demonstrating quantum computing capabilities that reportedly completed complex magnetic materials simulations in under 20 minutes—tasks that would require nearly a million years on traditional supercomputers.

The advent of weight-loss drugs, primarily semaglutide, proved to be an immense boon for biotech giants — primarily Novo Nordisk and Eli Lilly.

First United Corporation (FUNC) Could Be a Great Choice — Positive
FUNC Zacks Investment Research — March 28, 2025Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First United Corporation (FUNC) have what it takes?
